Deactivation of sodium tetradecyl sulphate injection by blood proteins

European Journal of Vascular and Endovascular Surgery

Volumn 41, Issue 4, 2011, Pages 521-525

  Watkins, M R ^a  

^a STD Pharmaceutical Products Ltd   (United Kingdom)

Author keywords

Albumin; Erythrocytes; Sclerosants; Sclerotherapy; Sodium tetradecyl sulphate

Indexed keywords

BOVINE SERUM ALBUMIN; PLASMA PROTEIN; SCLEROSING AGENT; SODIUM TETRADECYL SULPHATE; UNCLASSIFIED DRUG;

ARTICLE; BLOOD VOLUME; DRUG INACTIVATION; ERYTHROCYTE; INJECTION; NONHUMAN; PRIORITY JOURNAL; REPRODUCIBILITY; TITRIMETRY;

ANIMALS; BLOOD PROTEINS; CATTLE; COLORIMETRY; ERYTHROCYTES; INJECTIONS; REPRODUCIBILITY OF RESULTS; SCLEROSING SOLUTIONS; SCLEROTHERAPY; SERUM ALBUMIN, BOVINE; SODIUM TETRADECYL SULFATE;

EID: 79953052610     PISSN: 10785884     EISSN: 15322165     Source Type: Journal    
DOI: 10.1016/j.ejvs.2010.12.012     Document Type: Article

References (13)

1. Imhoff E, Stemmer R. Classification and mechanism of action of sclerosing agents. Phlebologie 1969;22:143-6.
2. Reiner L. The activity of anionic surface active compounds in producing vascular obliteration. Proc Soc Exper Biol Med 1946;62:49-54.
3. Fegan WG. Continuous compression technique of injecting varicose veins. Lancet 1963;11:109-12.
4. Fegan G. Varicose veins: compression sclerotherapy. London: Heinemann Medical; 1967.
5. Hobbs JT. Surgery or sclerotherapy for varicose veins: 10-year results of a random trial. In: Tesi M, Dormandy JA, editors. Superficial and deep venous diseases of the lower limbs. Turin: Panminerva Medica; Sept 1984. p. 243-8.
6. Parsi K, Exner T, Connor DE, Herbert A, Ma DD, Joseph JE. The lytic effects of detergent sclerosants on erythrocytes, platelets, endothelial cells and microparticles are attenuated by albumin and other plasma components in vitro. Eur J Vasc Endovasc Surg 2008;36:216-23. (Pubitemid 351952328)
7. British pharmacopoeia. Clifton House, Worship Street, London, EC2A 2EJ: By British Pharmacopoeia Commission. The Stationary Office Ltd; 2009.
8. Ouvry P, Allaert FA, Desnos P, Hamel-Desnos C. Efficacy of polidocanol foam versus liquid in sclerotherapy of the great saphenous vein: a multicentre randomised controlled trial with a 2-year follow-up. Eur J Vasc Endovasc Surg 2008;36:366-70.
9. Barrett JM, Allen B, Ockelford A, Goldman MP. Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10 mm or greater compared with a subgroup of less than 10 mm. Dermatol Surg 2004;30:1386-90. (Pubitemid 39552228)
10. Myers KA, Jolley D, Clough A, Kirwan J. Outcome of ultrasound-guided sclerotherapy for varicose veins: medium-term results assessed by ultrasound surveillance. Eur J Vasc Endovasc Surg 2007;33:116-21. (Pubitemid 44872674)
11. Gonzalez-Zeh R, Armisen R, Barahona S. Endovenous laser and echo-guided foam ablation in great saphenous vein reflux: oneyear follow-up results. J Vasc Surg 2008;48:940-6.
12. Parsi K. Catheter-directed sclerotherapy. Phlebology 2009;24:98-107.
13. Cavezzi A, Tessari L. Foam sclerotherapy techniques: different gases and methods of preparation, catheter versus direct injection. Phlebology 2009;24:247-51.